GoodRx Holdings, Inc. (GDRX) Costs and Expenses USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
GoodRx Holdings, Inc. quarterly/annual Costs and Expenses history and growth rate from 2018 to 2023.
  • GoodRx Holdings, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $190 M, a 10.3% increase year-over-year.
  • GoodRx Holdings, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $795 M, a 5.46% increase year-over-year.
  • GoodRx Holdings, Inc. annual Costs and Expenses for 2023 was $777 M, a 1.63% increase from 2022.
  • GoodRx Holdings, Inc. annual Costs and Expenses for 2022 was $765 M, a 4.48% increase from 2021.
  • GoodRx Holdings, Inc. annual Costs and Expenses for 2021 was $732 M, a 11.4% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $777 M +$12.5 M +1.63% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $765 M +$32.8 M +4.48% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $732 M -$94.4 M -11.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $826 M +$578 M +232% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $249 M +$76.3 M +44.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $172 M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.